Table 2. CF-DNA quantity (ng) in relation to the status (cancer/control).
| Gene | Overall(n = 89) | Cancer(n = 79) | Control(n = 10) | p-value# |
|---|---|---|---|---|
| Median (iqr range) | Median (iqr range) | Median (iqr range) | ||
| HER2 LONG | 0.031 (0.012–0.121) | 0.034 (0.011–0.137) | 0.023 (0.015–0.033) | 0.439 |
| HER2 SHORT | 0.202 (0.077–0.496) | 0.238 (0.093–0.509) | 0.067 (0.049–0.111) | 0.016 |
| BCAS1 LONG | 0.241 (0.093–0.820) | 0.266 (0.131–0.941) | 0.039 (0.031–0.460) | 0.021 |
| BCAS1 SHORT | 1.195 (0.476–2.069) | 1.259 (0.536–2.133) | 0.085 (0.050–0.916) | 0.001 |
| MYC LONG | 0.421 (0.190–1.192) | 0.421 (0.146–1.205) | 0.426 (0.299–0.533) | 0.658 |
| MYC SHORT | 1.124 (0.557–2.001) | 1.145 (0.557–2.255) | 0.771 (0.457–1.335) | 0.193 |
| PI3KCA LONG | 0.089 (0.036–0.347) | 0.108 (0.036–0.373) | 0.056 (0.044–0.092) | 0.398 |
| PI3KCA SHORT | 1.165 (0.231–3.434) | 1.619 (0.296–4.332) | 0.174 (0.140–0.390) | 0.001 |
#Two-sample Wilcoxon rank-sum (Mann-Whitney) test.